Drug intelligence / Profile preview

ganhuokangsheng granules

Development stage: Unknown
Lead developer: Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Administration: Oral

Overview

Ganhuokangsheng granules is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Shandong University of TCM. It is specifically formulated to treat the TCM syndrome of hyperactivity of liver fire (Gan Huo Kang Sheng), which is associated with early-stage hypertensive symptoms. The granules are being evaluated for their ability to provide vascular protection in individuals with high-normal blood pressure (pre-hypertension) and increased arterial stiffness. Clinical research focuses on its impact on carotid-femoral pulse wave velocity (cfPWV) and other markers of vascular health, aiming to prevent the transition to clinical hypertension.

Other names: Ganhuo Kangsheng granulesGanhuo Kangsheng Keli

Beyond the preview

Go deeper on ganhuokangsheng granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ganhuokangsheng granules.

Explore the full profile